The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Summary
The purpose of this research study is to see if a virtual reality (VR) headset is useful in reducing physical discomfort and anxiety experienced by patients who are scheduled to undergo a bone marrow biopsy (BMB) and/or bone marrow aspiration (BMA).
Detailed description
This will be a randomized controlled trial comparing standard of care to standard of care + VR intervention for adult participants who have or are suspected of having a malignant hematologic disorder and are scheduled for an outpatient bone marrow biopsy (BMB) and/or bone marrow aspiration (BMA). Participants will be randomized 1:1. Participants will be risk stratified based on whether they are undergoing a biopsy for the first time or not.
Arms & interventions
- OtherStandard of Care
Standard of care for a bone marrow biopsy/bone marrow aspiration includes routine site-specific lidocaine anesthetic.
- OtherVirtual Reality intervention
Participants will wear the VR headset (Quest 3 by Meta) during your bone marrow procedure.
Outcome measures
Primary
Numeric Rating Scale Pain Scores Immediately Post-biopsy
For each participant, the Numeric Rating Scale (NRS) score immediately post-biopsy will be captured indicating the participants' severity of pain. The score for each participant will be categorized into 6 ordinal categories (0 No Pain, 1-2 Very Mild, 3-4 Mild, 5-6 Moderate, 7-8 Severe, 9-10 Unbearable) and used to assess if those using the Virtual Reality Headset during the procedure experienced less overall pain immediately following the bone marrow biopsy.
Time frame: Single time point evaluation completed immediately following biopsy procedure
Secondary
Single time point evaluation completed immediately following biopsy procedure
Time frame: Single time point evaluation completed 24 hours after biopsy procedure.
State Trait Anxiety Inventory Trait-5 Change Score
Time frame: Two time point evaluations completed immediately following and 24 hours after biopsy procedure.
Likelihood to Repeat
Time frame: Single time point evaluation completed 24 hours after biopsy procedure.
Eligibility criteria
Study locations (1)
Levine Cancer Insitute
Charlotte, North Carolina, 28204